WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HB 389

Legislative bill overview

HB 389 proposes amendments to Utah's medical cannabis program, though specific provisions are not detailed in the available action history. The bill has recently entered the legislative process with fiscal analysis underway, indicating it involves budgetary considerations alongside policy changes to the existing medical cannabis framework.

Why is this important

Utah's medical cannabis program directly affects patient access to treatment options and state regulatory capacity. Any amendments could impact the program's scope, implementation costs, patient eligibility, or licensing requirements—affecting both healthcare access and state budget allocation.

Potential points of contention

  • Program expansion vs. fiscal conservatism: Whether amendments expand access (increasing state costs) or restrict the program depends on specific provisions; fiscal note suggests budget implications are central to debate
  • Patient access concerns: Amendments could broaden or narrow who qualifies for medical cannabis, affecting patient populations depending on disease criteria changes
  • Regulatory and enforcement scope: Changes may alter how heavily the state regulates dispensaries, testing, or patient verification—balancing safety oversight with program feasibility

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.